

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.00642212 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.00642212 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.00642212 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.00642212 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.00642212 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.00642212 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.75036440 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.38840046 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.99013109 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.71973023 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.67238848 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.61562275 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.61562275 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.56236572 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.45753680 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.45753680 |
| 17 | positive regulation of interferon-alpha production (GO:0032727) | 4.44922545 |
| 18 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 4.34877827 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.27252281 |
| 20 | regulation of interferon-alpha production (GO:0032647) | 4.24689136 |
| 21 | detection of other organism (GO:0098543) | 4.23917884 |
| 22 | response to peptidoglycan (GO:0032494) | 4.11510442 |
| 23 | detection of bacterium (GO:0016045) | 4.04515045 |
| 24 | response to host immune response (GO:0052572) | 3.96738943 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.96738943 |
| 26 | respiratory burst (GO:0045730) | 3.92743313 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 3.87490483 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.87473651 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.85550272 |
| 30 | microglial cell activation (GO:0001774) | 3.78769073 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 3.78314567 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77672123 |
| 33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.76961638 |
| 34 | neutrophil activation (GO:0042119) | 3.71885352 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.71053517 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71035587 |
| 37 | * B cell receptor signaling pathway (GO:0050853) | 3.71033690 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70740810 |
| 39 | response to host (GO:0075136) | 3.69958209 |
| 40 | response to host defenses (GO:0052200) | 3.69958209 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.69958209 |
| 42 | positive T cell selection (GO:0043368) | 3.62958326 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.61925633 |
| 44 | leukocyte aggregation (GO:0070486) | 3.61873305 |
| 45 | granulocyte activation (GO:0036230) | 3.60082934 |
| 46 | T cell selection (GO:0045058) | 3.52365284 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.49959882 |
| 48 | * positive regulation of B cell differentiation (GO:0045579) | 3.47804948 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.45092995 |
| 50 | cellular extravasation (GO:0045123) | 3.43376371 |
| 51 | * regulation of B cell differentiation (GO:0045577) | 3.35250968 |
| 52 | positive regulation of granulocyte differentiation (GO:0030854) | 3.34518350 |
| 53 | response to interleukin-15 (GO:0070672) | 3.30651645 |
| 54 | pinocytosis (GO:0006907) | 3.28796964 |
| 55 | positive thymic T cell selection (GO:0045059) | 3.28414909 |
| 56 | positive regulation of interferon-beta production (GO:0032728) | 3.27958152 |
| 57 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27304098 |
| 58 | thymic T cell selection (GO:0045061) | 3.27086538 |
| 59 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.26966052 |
| 60 | natural killer cell mediated immunity (GO:0002228) | 3.26966052 |
| 61 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.26782787 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 3.24758596 |
| 63 | defense response to protozoan (GO:0042832) | 3.23886202 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 3.23785715 |
| 65 | B cell mediated immunity (GO:0019724) | 3.22563649 |
| 66 | neutrophil mediated immunity (GO:0002446) | 3.21787535 |
| 67 | myeloid dendritic cell activation (GO:0001773) | 3.21462575 |
| 68 | macrophage activation (GO:0042116) | 3.21182192 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.21162942 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.19782069 |
| 71 | regulation of leukocyte degranulation (GO:0043300) | 3.18934697 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 3.18525049 |
| 73 | tolerance induction (GO:0002507) | 3.18523043 |
| 74 | germinal center formation (GO:0002467) | 3.18436702 |
| 75 | negative regulation of granulocyte differentiation (GO:0030853) | 3.15962199 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.15324196 |
| 77 | positive regulation of mast cell degranulation (GO:0043306) | 3.15324196 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12924854 |
| 79 | regulation of tolerance induction (GO:0002643) | 3.10513618 |
| 80 | T cell migration (GO:0072678) | 3.10033522 |
| 81 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.09116387 |
| 82 | mature B cell differentiation (GO:0002335) | 3.08062276 |
| 83 | response to type I interferon (GO:0034340) | 3.07896974 |
| 84 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.07521252 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 3.06820259 |
| 86 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05892467 |
| 87 | type I interferon signaling pathway (GO:0060337) | 3.05316022 |
| 88 | cellular response to type I interferon (GO:0071357) | 3.05316022 |
| 89 | activated T cell proliferation (GO:0050798) | 3.03738958 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 3.03212230 |
| 91 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.02147781 |
| 92 | negative thymic T cell selection (GO:0045060) | 3.01662187 |
| 93 | I-kappaB phosphorylation (GO:0007252) | 3.01591499 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 3.00365472 |
| 95 | response to protozoan (GO:0001562) | 2.98957606 |
| 96 | myeloid dendritic cell differentiation (GO:0043011) | 2.98079907 |
| 97 | myeloid leukocyte activation (GO:0002274) | 2.96578640 |
| 98 | cellular response to interleukin-15 (GO:0071350) | 2.96506395 |
| 99 | negative T cell selection (GO:0043383) | 2.94005256 |
| 100 | mast cell activation (GO:0045576) | 2.93533632 |
| 101 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92728937 |
| 102 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.92548766 |
| 103 | positive regulation of mast cell activation (GO:0033005) | 2.92400538 |
| 104 | regulation of mast cell activation (GO:0033003) | 2.91695817 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.90278881 |
| 106 | leukocyte cell-cell adhesion (GO:0007159) | 2.89542504 |
| 107 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.88379033 |
| 108 | regulation of granulocyte differentiation (GO:0030852) | 2.85459472 |
| 109 | negative regulation of B cell proliferation (GO:0030889) | 2.83363144 |
| 110 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82665819 |
| 111 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81773449 |
| 112 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.81060670 |
| 113 | * regulation of gamma-delta T cell activation (GO:0046643) | 2.80517803 |
| 114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.79962128 |
| 115 | cellular response to zinc ion (GO:0071294) | 2.79820587 |
| 116 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.76986550 |
| 117 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.74023517 |
| 118 | leukocyte mediated cytotoxicity (GO:0001909) | 2.72302559 |
| 119 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.69076452 |
| 120 | leukocyte degranulation (GO:0043299) | 2.68178445 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.67110935 |
| 122 | * regulation of gamma-delta T cell differentiation (GO:0045586) | 2.67033363 |
| 123 | dendritic cell differentiation (GO:0097028) | 2.67018295 |
| 124 | interferon-gamma production (GO:0032609) | 2.65780954 |
| 125 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.63059001 |
| 126 | B cell proliferation (GO:0042100) | 2.62429582 |
| 127 | cellular response to interferon-beta (GO:0035458) | 2.62199745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.63039445 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.42205181 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.22450611 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.05860837 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.92030132 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.77437488 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.75336657 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.74177561 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71091678 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.60593468 |
| 11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35984078 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34143565 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.06603123 |
| 14 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.04729663 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88429249 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81585680 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.81253753 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65196159 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.57216151 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53582847 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.49975848 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.48457398 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.42766995 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38736304 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.30994220 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28823868 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.27923217 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27383142 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.22425842 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.20180378 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16515361 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.16203762 |
| 33 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.13237228 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12073189 |
| 35 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11026131 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 2.03946690 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85917834 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85623647 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84708958 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83910374 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81241689 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80300763 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79814069 |
| 44 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.73456000 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71252312 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69010320 |
| 47 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66563857 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49530153 |
| 49 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48848099 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48393173 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47314368 |
| 52 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45361564 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40628400 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38485309 |
| 55 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36810706 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35293260 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34869439 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34585312 |
| 59 | * MAF_26560356_Chip-Seq_TH2_Human | 1.29436976 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28383204 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26790029 |
| 62 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23401888 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23150647 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23048112 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22741584 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22492517 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19937471 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17614688 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16719140 |
| 70 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13759405 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13425978 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10861409 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10318355 |
| 74 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10177990 |
| 75 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08536374 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06296870 |
| 77 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04685210 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03185652 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00376457 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99469482 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99274641 |
| 82 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98171075 |
| 83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98015028 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96391782 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94268702 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93844521 |
| 87 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93450526 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92434592 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87567938 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86512568 |
| 91 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.85164720 |
| 92 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.83442431 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82598942 |
| 94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.82438440 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80711744 |
| 96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.80004373 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79568030 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79548030 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78738381 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77829275 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76485670 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75227522 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73395143 |
| 104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.67902491 |
| 105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67551834 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67322071 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65514579 |
| 108 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.64944489 |
| 109 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62480257 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62193352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.39515924 |
| 2 | MP0003303_peritoneal_inflammation | 3.43525719 |
| 3 | MP0003436_decreased_susceptibility_to | 3.30767989 |
| 4 | MP0001800_abnormal_humoral_immune | 3.03459881 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.01924303 |
| 6 | MP0001790_abnormal_immune_system | 2.97880597 |
| 7 | MP0005387_immune_system_phenotype | 2.97880597 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.97019609 |
| 9 | MP0000685_abnormal_immune_system | 2.96899128 |
| 10 | MP0005671_abnormal_response_to | 2.92601853 |
| 11 | * MP0002419_abnormal_innate_immunity | 2.89300610 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.86667083 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.84797106 |
| 14 | MP0009785_altered_susceptibility_to | 2.77773356 |
| 15 | MP0006082_CNS_inflammation | 2.69390427 |
| 16 | MP0005025_abnormal_response_to | 2.65999637 |
| 17 | * MP0002723_abnormal_immune_serum | 2.64352575 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.57282944 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.55103193 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.51464149 |
| 21 | * MP0001819_abnormal_immune_cell | 2.51056396 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.43453520 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.14231792 |
| 24 | * MP0002398_abnormal_bone_marrow | 2.13927481 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.12862263 |
| 26 | MP0004510_myositis | 2.04411712 |
| 27 | * MP0000716_abnormal_immune_system | 2.03244491 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.01988084 |
| 29 | * MP0002405_respiratory_system_inflammati | 1.95615372 |
| 30 | MP0009278_abnormal_bone_marrow | 1.94928278 |
| 31 | * MP0000689_abnormal_spleen_morphology | 1.92167721 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.90389584 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.84386861 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.83934922 |
| 35 | MP0004947_skin_inflammation | 1.82208510 |
| 36 | MP0003724_increased_susceptibility_to | 1.80124911 |
| 37 | * MP0001845_abnormal_inflammatory_respons | 1.75113042 |
| 38 | * MP0002722_abnormal_immune_system | 1.74984900 |
| 39 | MP0002006_tumorigenesis | 1.69904697 |
| 40 | * MP0002429_abnormal_blood_cell | 1.69675509 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.69418575 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.69199937 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.64690594 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.64371196 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.64371196 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.61940784 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.58057149 |
| 48 | MP0001873_stomach_inflammation | 1.54986611 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.48974706 |
| 50 | MP0005310_abnormal_salivary_gland | 1.46871100 |
| 51 | MP0009840_abnormal_foam_cell | 1.44257366 |
| 52 | * MP0008469_abnormal_protein_level | 1.43163411 |
| 53 | MP0003448_altered_tumor_morphology | 1.42298889 |
| 54 | MP0005451_abnormal_body_composition | 1.39608818 |
| 55 | MP0010307_abnormal_tumor_latency | 1.39608179 |
| 56 | MP0008260_abnormal_autophagy | 1.38310830 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.34643694 |
| 58 | * MP0000703_abnormal_thymus_morphology | 1.30719145 |
| 59 | MP0000858_altered_metastatic_potential | 1.23038512 |
| 60 | MP0000343_altered_response_to | 1.21366515 |
| 61 | MP0004381_abnormal_hair_follicle | 1.18967786 |
| 62 | MP0002933_joint_inflammation | 1.18587813 |
| 63 | * MP0001853_heart_inflammation | 1.16442673 |
| 64 | MP0004883_abnormal_blood_vessel | 1.15163504 |
| 65 | MP0000490_abnormal_crypts_of | 1.13475387 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.09576730 |
| 67 | MP0001851_eye_inflammation | 1.09116802 |
| 68 | MP0003866_abnormal_defecation | 1.08521246 |
| 69 | MP0002009_preneoplasia | 1.07374053 |
| 70 | MP0009764_decreased_sensitivity_to | 1.05861952 |
| 71 | MP0003075_altered_response_to | 1.03916018 |
| 72 | MP0002132_abnormal_respiratory_system | 1.02262739 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.00542262 |
| 74 | MP0000371_diluted_coat_color | 0.94750327 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.90335657 |
| 76 | MP0005166_decreased_susceptibility_to | 0.89977559 |
| 77 | MP0003690_abnormal_glial_cell | 0.89220091 |
| 78 | MP0009763_increased_sensitivity_to | 0.85890802 |
| 79 | MP0003828_pulmonary_edema | 0.85405029 |
| 80 | MP0010352_gastrointestinal_tract_polyps | 0.81271451 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.79806605 |
| 82 | MP0005164_abnormal_response_to | 0.78930684 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.78094194 |
| 84 | MP0008004_abnormal_stomach_pH | 0.75330944 |
| 85 | MP0000249_abnormal_blood_vessel | 0.71946982 |
| 86 | MP0002095_abnormal_skin_pigmentation | 0.71723640 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.70737218 |
| 88 | MP0003091_abnormal_cell_migration | 0.69463757 |
| 89 | MP0005390_skeleton_phenotype | 0.69217560 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.67604625 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.67457197 |
| 92 | MP0009115_abnormal_fat_cell | 0.66307243 |
| 93 | MP0005023_abnormal_wound_healing | 0.64812609 |
| 94 | MP0008057_abnormal_DNA_replication | 0.61554079 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.61436396 |
| 96 | MP0003795_abnormal_bone_structure | 0.60352059 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.58586664 |
| 98 | MP0001663_abnormal_digestive_system | 0.58560612 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.58027575 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.56093848 |
| 101 | * MP0000604_amyloidosis | 0.55892037 |
| 102 | MP0001915_intracranial_hemorrhage | 0.55539420 |
| 103 | MP0008873_increased_physiological_sensi | 0.55097228 |
| 104 | MP0002254_reproductive_system_inflammat | 0.54440417 |
| 105 | MP0008874_decreased_physiological_sensi | 0.54433153 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.53189275 |
| 107 | MP0002928_abnormal_bile_duct | 0.53108770 |
| 108 | MP0004130_abnormal_muscle_cell | 0.52150730 |
| 109 | MP0008007_abnormal_cellular_replicative | 0.52066054 |
| 110 | MP0003077_abnormal_cell_cycle | 0.52049788 |
| 111 | MP0000313_abnormal_cell_death | 0.52005502 |
| 112 | MP0003221_abnormal_cardiomyocyte_apopto | 0.51405053 |
| 113 | * MP0003656_abnormal_erythrocyte_physiolo | 0.51002921 |
| 114 | MP0003045_fibrosis | 0.50459786 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.50413797 |
| 116 | MP0005621_abnormal_cell_physiology | 0.50158669 |
| 117 | * MP0000609_abnormal_liver_physiology | 0.48775591 |
| 118 | MP0000920_abnormal_myelination | 0.48079490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.49978507 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.94118434 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.50612376 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.34886352 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.23324739 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.20790057 |
| 7 | Recurrent viral infections (HP:0004429) | 4.17017921 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.11004148 |
| 9 | Myositis (HP:0100614) | 3.95151745 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.93220066 |
| 11 | Recurrent skin infections (HP:0001581) | 3.92007633 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87528734 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.86278769 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.76522418 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.74861901 |
| 16 | Cellulitis (HP:0100658) | 3.69441534 |
| 17 | Obstructive lung disease (HP:0006536) | 3.49572572 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.49572572 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.40605422 |
| 20 | Chronic otitis media (HP:0000389) | 3.32423036 |
| 21 | Colitis (HP:0002583) | 3.31118613 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.30745287 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.30745287 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.30745287 |
| 25 | Stomatitis (HP:0010280) | 3.29523035 |
| 26 | Meningitis (HP:0001287) | 3.29191906 |
| 27 | Gingivitis (HP:0000230) | 3.26555233 |
| 28 | Inflammation of the large intestine (HP:0002037) | 3.22047339 |
| 29 | Orchitis (HP:0100796) | 3.21119001 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.18276078 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.18276078 |
| 32 | Vasculitis (HP:0002633) | 3.17298458 |
| 33 | IgM deficiency (HP:0002850) | 3.13903355 |
| 34 | Dysostosis multiplex (HP:0000943) | 3.08931451 |
| 35 | Optic neuritis (HP:0100653) | 3.08742385 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 3.08742385 |
| 37 | Gastrointestinal inflammation (HP:0004386) | 3.08073453 |
| 38 | Agammaglobulinemia (HP:0004432) | 3.05181943 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 3.04505732 |
| 40 | Periodontitis (HP:0000704) | 3.01174423 |
| 41 | Disinhibition (HP:0000734) | 2.96485000 |
| 42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90611090 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.88924130 |
| 44 | Pustule (HP:0200039) | 2.86811863 |
| 45 | Osteomyelitis (HP:0002754) | 2.86424445 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.78662047 |
| 47 | Chest pain (HP:0100749) | 2.78422988 |
| 48 | Hematochezia (HP:0002573) | 2.74955945 |
| 49 | Glomerulonephritis (HP:0000099) | 2.73071982 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.71497339 |
| 51 | Keratoconjunctivitis sicca (HP:0001097) | 2.69712491 |
| 52 | Leukocytosis (HP:0001974) | 2.69707168 |
| 53 | T lymphocytopenia (HP:0005403) | 2.59768733 |
| 54 | Eosinophilia (HP:0001880) | 2.57925983 |
| 55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57410021 |
| 56 | Agnosia (HP:0010524) | 2.57104733 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.56998238 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.52961340 |
| 59 | Thyroiditis (HP:0100646) | 2.52833478 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.49516686 |
| 61 | Mucopolysacchariduria (HP:0008155) | 2.49516686 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.49360436 |
| 63 | Thrombocytosis (HP:0001894) | 2.48853200 |
| 64 | Keratoconjunctivitis (HP:0001096) | 2.48668995 |
| 65 | Arterial thrombosis (HP:0004420) | 2.48605231 |
| 66 | Autoimmune hemolytic anemia (HP:0001890) | 2.44309912 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43894472 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43894472 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43894472 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.42991624 |
| 71 | Recurrent pneumonia (HP:0006532) | 2.42389274 |
| 72 | Nasal polyposis (HP:0100582) | 2.40393993 |
| 73 | Abnormality of T cells (HP:0002843) | 2.38795239 |
| 74 | Axonal loss (HP:0003447) | 2.38583960 |
| 75 | Loss of speech (HP:0002371) | 2.38081500 |
| 76 | Gingival bleeding (HP:0000225) | 2.37579133 |
| 77 | Gastrointestinal stroma tumor (HP:0100723) | 2.35950587 |
| 78 | Prostate neoplasm (HP:0100787) | 2.32612590 |
| 79 | Viral hepatitis (HP:0006562) | 2.32504484 |
| 80 | Petechiae (HP:0000967) | 2.32441204 |
| 81 | Basal ganglia calcification (HP:0002135) | 2.30567127 |
| 82 | Increased IgM level (HP:0003496) | 2.29963650 |
| 83 | Pulmonary embolism (HP:0002204) | 2.27488660 |
| 84 | Granulocytopenia (HP:0001913) | 2.26624632 |
| 85 | Lymphopenia (HP:0001888) | 2.26434965 |
| 86 | Abnormality of the fingertips (HP:0001211) | 2.26144487 |
| 87 | Epistaxis (HP:0000421) | 2.25939129 |
| 88 | Urticaria (HP:0001025) | 2.25324139 |
| 89 | Myocardial infarction (HP:0001658) | 2.22097993 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20819777 |
| 91 | Recurrent sinusitis (HP:0011108) | 2.17402786 |
| 92 | Abnormality of T cell physiology (HP:0011840) | 2.17277474 |
| 93 | Chronic diarrhea (HP:0002028) | 2.17127680 |
| 94 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16718553 |
| 95 | Abnormal platelet function (HP:0011869) | 2.16205727 |
| 96 | Impaired platelet aggregation (HP:0003540) | 2.16205727 |
| 97 | Abnormality of the prostate (HP:0008775) | 2.16094835 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 2.15885111 |
| 99 | Increased IgE level (HP:0003212) | 2.15220978 |
| 100 | Restrictive lung disease (HP:0002091) | 2.14982346 |
| 101 | Abnormality of eosinophils (HP:0001879) | 2.14305450 |
| 102 | Thoracic kyphosis (HP:0002942) | 2.12929950 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.12604470 |
| 104 | Sepsis (HP:0100806) | 2.12473877 |
| 105 | Purpura (HP:0000979) | 2.12431910 |
| 106 | Hemoptysis (HP:0002105) | 2.11873114 |
| 107 | B lymphocytopenia (HP:0010976) | 2.11325632 |
| 108 | Abnormality of B cell number (HP:0010975) | 2.11325632 |
| 109 | Amaurosis fugax (HP:0100576) | 2.09020240 |
| 110 | Encephalitis (HP:0002383) | 2.07206058 |
| 111 | Hepatosplenomegaly (HP:0001433) | 2.06999640 |
| 112 | Verrucae (HP:0200043) | 2.06590489 |
| 113 | Papilloma (HP:0012740) | 2.06590489 |
| 114 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05725990 |
| 115 | Abnormality of the pleura (HP:0002103) | 2.05717421 |
| 116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.99115130 |
| 117 | Combined immunodeficiency (HP:0005387) | 1.98570436 |
| 118 | Increased serum ferritin (HP:0003281) | 1.97329334 |
| 119 | IgG deficiency (HP:0004315) | 1.97116297 |
| 120 | Skin ulcer (HP:0200042) | 1.95752168 |
| 121 | Severe combined immunodeficiency (HP:0004430) | 1.93655444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.33566477 |
| 2 | TYK2 | 3.20432197 |
| 3 | BLK | 3.00059297 |
| 4 | PRPF4B | 2.89995959 |
| 5 | KIT | 2.85423794 |
| 6 | RIPK4 | 2.84794440 |
| 7 | MAP3K14 | 2.78026902 |
| 8 | IRAK4 | 2.72690139 |
| 9 | TBK1 | 2.63357631 |
| 10 | CSF1R | 2.44667037 |
| 11 | TXK | 2.35863487 |
| 12 | TGFBR2 | 2.35465605 |
| 13 | JAK3 | 2.31030504 |
| 14 | IRAK3 | 2.16291175 |
| 15 | IKBKE | 2.11546291 |
| 16 | ZAP70 | 2.10486815 |
| 17 | JAK1 | 1.95527113 |
| 18 | ERN1 | 1.91664270 |
| 19 | SYK | 1.90841375 |
| 20 | MAP3K13 | 1.89882230 |
| 21 | BTK | 1.89792089 |
| 22 | IKBKB | 1.88756997 |
| 23 | STK10 | 1.88186579 |
| 24 | FES | 1.74771244 |
| 25 | HCK | 1.70469621 |
| 26 | TAOK3 | 1.61829757 |
| 27 | MAP2K3 | 1.53914452 |
| 28 | MAP3K10 | 1.53142127 |
| 29 | CSK | 1.53079765 |
| 30 | ITK | 1.51486349 |
| 31 | LCK | 1.46118578 |
| 32 | TEC | 1.44963714 |
| 33 | EEF2K | 1.43932588 |
| 34 | GRK6 | 1.43492667 |
| 35 | BMPR2 | 1.36958202 |
| 36 | SIK2 | 1.31011716 |
| 37 | LYN | 1.30228737 |
| 38 | EPHB1 | 1.20342293 |
| 39 | CLK1 | 1.19028320 |
| 40 | PIK3CG | 1.18465378 |
| 41 | CAMK1D | 1.16088314 |
| 42 | RPS6KA4 | 1.13861162 |
| 43 | CHUK | 1.13516481 |
| 44 | PKN2 | 1.12253377 |
| 45 | PIM1 | 1.11265154 |
| 46 | CDK12 | 1.09807899 |
| 47 | JAK2 | 1.03141043 |
| 48 | TRIB3 | 1.01412386 |
| 49 | LRRK2 | 0.98603438 |
| 50 | FGFR3 | 0.98553666 |
| 51 | NEK9 | 0.91529835 |
| 52 | STK4 | 0.91278524 |
| 53 | MAP3K1 | 0.90864311 |
| 54 | MARK3 | 0.90565762 |
| 55 | MATK | 0.88445123 |
| 56 | FGFR4 | 0.85923841 |
| 57 | CAMK1G | 0.84916383 |
| 58 | FGR | 0.84422445 |
| 59 | TTN | 0.84390315 |
| 60 | SCYL2 | 0.81910725 |
| 61 | CDC42BPA | 0.79267260 |
| 62 | FLT3 | 0.78417045 |
| 63 | PTK6 | 0.77602085 |
| 64 | IRAK1 | 0.76780245 |
| 65 | NME2 | 0.76015664 |
| 66 | TRPM7 | 0.75232932 |
| 67 | CDK6 | 0.74133873 |
| 68 | TAOK1 | 0.74048084 |
| 69 | MARK2 | 0.68877351 |
| 70 | CAMKK1 | 0.68672506 |
| 71 | PDPK1 | 0.63927352 |
| 72 | TAOK2 | 0.63082371 |
| 73 | KSR2 | 0.60753471 |
| 74 | NEK2 | 0.60614668 |
| 75 | PAK4 | 0.60208150 |
| 76 | CDK4 | 0.59615378 |
| 77 | PIM2 | 0.58391979 |
| 78 | EGFR | 0.58351938 |
| 79 | IRAK2 | 0.57669694 |
| 80 | MAP3K6 | 0.56313361 |
| 81 | GRK7 | 0.55829008 |
| 82 | PRKCQ | 0.51251815 |
| 83 | ABL1 | 0.51007883 |
| 84 | MAP3K3 | 0.50787738 |
| 85 | PDK1 | 0.48588416 |
| 86 | SMG1 | 0.46622681 |
| 87 | MAP3K7 | 0.45226163 |
| 88 | MAPKAPK2 | 0.43964507 |
| 89 | PRKCD | 0.42023191 |
| 90 | MAP3K8 | 0.41836736 |
| 91 | RPS6KA6 | 0.41241235 |
| 92 | RET | 0.39007075 |
| 93 | SGK2 | 0.38550996 |
| 94 | TNK2 | 0.38138238 |
| 95 | YES1 | 0.37134253 |
| 96 | RIPK1 | 0.34999275 |
| 97 | FYN | 0.34699712 |
| 98 | MAP2K6 | 0.34488813 |
| 99 | CDK9 | 0.34073212 |
| 100 | CAMKK2 | 0.33839918 |
| 101 | HIPK2 | 0.33316390 |
| 102 | TESK2 | 0.33185761 |
| 103 | MAPK4 | 0.32452140 |
| 104 | NLK | 0.32041137 |
| 105 | ALK | 0.31727892 |
| 106 | MAPK12 | 0.31572479 |
| 107 | PRKCH | 0.31369729 |
| 108 | MOS | 0.30619372 |
| 109 | ATR | 0.29899638 |
| 110 | BRD4 | 0.29895742 |
| 111 | ACVR1B | 0.29496859 |
| 112 | RPS6KC1 | 0.28792678 |
| 113 | RPS6KL1 | 0.28792678 |
| 114 | MAPK11 | 0.28765487 |
| 115 | CAMK4 | 0.26936132 |
| 116 | EPHA3 | 0.26220749 |
| 117 | PRKD2 | 0.25795053 |
| 118 | MAP3K11 | 0.25458390 |
| 119 | IGF1R | 0.24486561 |
| 120 | MAP3K5 | 0.24411464 |
| 121 | SGK3 | 0.24171795 |
| 122 | PDGFRB | 0.23173577 |
| 123 | MAPK7 | 0.21842260 |
| 124 | SIK3 | 0.21529480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.07240233 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.80704177 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.73372316 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61681498 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54305377 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53400310 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.33008806 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.21984165 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.20519774 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06417960 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04675641 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00152553 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98854521 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.96853370 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.93711190 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.93679790 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.92047964 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89688605 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.85456245 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84870874 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81672662 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.76258196 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.66465253 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62416488 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.61394498 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61267904 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.60110376 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58586293 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57106992 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56863397 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.55615665 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52570698 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.45907492 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45366441 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43830633 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.40747073 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40295082 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.30636452 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22062932 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22004316 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.21356170 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.20330783 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18731497 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18163480 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17642247 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.15988256 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07534224 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05723659 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.02574104 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01293691 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.96090848 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92392768 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91942294 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89733161 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89134775 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88385974 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88283338 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87496262 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.82269236 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74388808 |
| 61 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73878755 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72984425 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68877424 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67538333 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67285123 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65236663 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63925703 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63855022 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62809237 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61698293 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60981092 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59395873 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59382318 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.58243922 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55238730 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54666113 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.52005269 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51501451 |
| 79 | DNA replication_Homo sapiens_hsa03030 | 0.50518395 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50326687 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49935526 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.47960411 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47946336 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46215773 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44592952 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43927570 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43711797 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43520828 |
| 89 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43450178 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41717887 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39946043 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39552215 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.39150330 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38865162 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38592079 |
| 96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38226087 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37682002 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35752737 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35032804 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34539838 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34340949 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29606376 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.29515799 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29440749 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28292672 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27018548 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26941810 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26785624 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25522612 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.24171631 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.20978845 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19993852 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18652253 |
| 114 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.18609128 |

